Works matching IS 14642662 AND DT 2012 AND VI 13 AND IP 4

Results: 11

Twenty-four-week efficacy and safety of switching virologically suppressed HIV-1-infected patients from nevirapine immediate release 200 mg twice daily to nevirapine extended release 400 mg once daily ( TRANxITION)

Published in:

2012

By:

Arasteh, K;
Ward, D;
Plettenberg, A;
Livrozet, Jm;
Orkin, C;
Cordes, C;
Guo, J;
Wang, E;
Yong, Cl;
Robinson, P;
Quinson, A

Publication type:

Journal Article

Emergence of an HIV-1 cluster harbouring the major protease L90M mutation among treatment-naïve patients in Tel Aviv, Israel.

Published in:

2012

By:

Turner, D;
Amit, S;
Chalom, S;
Penn, O;
Pupko, T;
Katchman, E;
Matus, N;
Tellio, H;
Katzir, M;
Avidor, B

Publication type:

Journal Article

Strong serological responses and HIV RNA increase following AS03-adjuvanted pandemic immunization in HIV-infected patients.

Published in:

HIV Medicine, 2012, v. 13, n. 4, p. 207, doi. 10.1111/j.1468-1293.2011.00961.x

By:

Calmy, A;
Bel, M;
Nguyen, A;
Combescure, C;
Delhumeau, C;
Meier, S;
Yerly, S;
Kaiser, L;
Hirschel, B;
Siegrist, C-A;
Siegrist, C. A.;
Posfay-Barbe, K.;
Meier, S.;
Bel, M.;
Grillet, S.;
Sealy, G.;
Demeules, J.;
Charvat, S.;
Verdon, M.;
Combescure, C.

Publication type:

Article

Effect of pregnancy on emtricitabine pharmacokinetics.

Published in:

HIV Medicine, 2012, v. 13, n. 4, p. 226, doi. 10.1111/j.1468-1293.2011.00965.x

By:

Stek, AM;
Best, BM;
Luo, W;
Capparelli, E;
Burchett, S;
Hu, C;
Li, H;
Read, JS;
Jennings, A;
Barr, E;
Smith, E;
Rossi, SS;
Mirochnick, M

Publication type:

Article

Twenty-four-week efficacy and safety of switching virologically suppressed HIV-1-infected patients from nevirapine immediate release 200 mg twice daily to nevirapine extended release 400 mg once daily ( TRANxITION).

Published in:

HIV Medicine, 2012, v. 13, n. 4, p. 236, doi. 10.1111/j.1468-1293.2011.00969.x

By:

Arasteh, K;
Ward, D;
Plettenberg, A;
Livrozet, JM;
Orkin, C;
Cordes, C;
Guo, J;
Wang, E;
Yong, CL;
Robinson, P;
Quinson, A

Publication type:

Article

Emergence of an HIV-1 cluster harbouring the major protease L90M mutation among treatment-naïve patients in Tel Aviv, Israel.

Published in:

HIV Medicine, 2012, v. 13, n. 4, p. 202, doi. 10.1111/j.1468-1293.2011.00960.x

By:

Turner, D;
Amit, S;
Chalom, S;
Penn, O;
Pupko, T;
Katchman, E;
Matus, N;
Tellio, H;
Katzir, M;
Avidor, B

Publication type:

Article

Efavirenz dose reduction in HIV-infected patients.

Published in:

HIV Medicine, 2012, v. 13, n. 4, p. 252, doi. 10.1111/j.1468-1293.2011.00964.x

By:

Lanzafame, M;
Bonora, S;
Lattuada, E;
Vento, S

Publication type:

Article

Pharmacokinetics of the nonnucleoside reverse transcriptase inhibitor efavirenz among HIV-infected Ugandans.

Published in:

HIV Medicine, 2012, v. 13, n. 4, p. 193, doi. 10.1111/j.1468-1293.2011.00952.x

By:

Nanzigu, S;
Eriksen, J;
Makumbi, F;
Lanke, S;
Mahindi, M;
Kiguba, R;
Beck, O;
Ma, Q;
Morse, GD;
Gustafsson, LL;
Waako, P

Publication type:

Article

Population mobility and the changing epidemics of HIV-2 in Portugal.

Published in:

HIV Medicine, 2012, v. 13, n. 4, p. 219, doi. 10.1111/j.1468-1293.2011.00963.x

By:

Carvalho, AC;
Valadas, E;
França, L;
Carvalho, C;
Aleixo, MJ;
Mendez, J;
Marques, R;
Sarmento, A;
Doroana, M;
Antunes, F;
Branco, T;
Águas, M;
Sarmento e Castro, R;
Lazarus, JV;
Barros, H

Publication type:

Article

Dynamics of cognitive change in HIV-infected individuals commencing three different initial antiretroviral regimens: a randomized, controlled study.

Published in:

HIV Medicine, 2012, v. 13, n. 4, p. 245, doi. 10.1111/j.1468-1293.2011.00962.x

By:

Winston, A;
Puls, R;
Kerr, SJ;
Duncombe, C;
Li, PCK;
Gill, JM;
Taylor-Robinson, SD;
Emery, S;
Cooper, DA

Publication type:

Article

Corrigendum.

Published in:: HIV Medicine, 2012, v. 13, n. 4, p. 253, doi. 10.1111/j.1468-1293.2011.00966.x
Publication type:: Article